Evidence map›Paper›PMID 27864331›Full record

ArticleThe Journal of biological chemistry2016

Role of Sphingosine Kinase 1 and S1P Transporter Spns2 in HGF-mediated Lamellipodia Formation in Lung Endothelium.

Panfeng Fu, David L Ebenezer, Evgeny V Berdyshev, Irina A Bronova, Mark Shaaya, Anantha Harijith, Viswanathan Natarajan

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Cortactin in Lung Cell Function and Disease.International journal of molecular sciences · 2022
    Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Programming to S1PR1Circulation research · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Bioactive lysolipids in cancer and angiogenesis.Pharmacology & therapeutics · 2019
    Review
  20. The implications of signaling lipids in cancer metastasis.Experimental & molecular medicine · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Panfeng FuFrom the Departments of Pharmacology.
David L EbenezerBiochemistry and Molecular Genetics.
Evgeny V Berdyshevthe Department of Medicine, National Jewish Health, Denver, Colorado 80206.
Irina A Bronovathe Department of Medicine, National Jewish Health, Denver, Colorado 80206.
Mark ShaayaFrom the Departments of Pharmacology.
Anantha HarijithPediatrics, and.
Viswanathan NatarajanFrom the Departments of Pharmacology, visnatar@uic.edu.
National Jewish Health · USPediatrics and Genetics · USUniversity of Colorado Denver · USUniversity of Illinois Chicago · US

Funding

TRPC6 Regulation of Lung Endothelial Barrier FunctionP01HL060678 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MALIK, ASRAR B. · 2000 to 2020
$40.1M
TRAINING PROGRAM IN LUNG BIOLOGY AND PATHOBIOLOGYT32HL007829 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DOLLY MEHTA · 1995 to 2026
$15.6M
Therapeutic Potential of FTY720 Analogues in Lung InjuryP01HL098050 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI NATARAJAN, VISWANATHAN · 2011 to 2015
$10.9M
NHLBI NIH HHS P01 HL060678NHLBI NIH HHS P01 HL098050NHLBI NIH HHS T32 HL007829
6 · The paper itself

Abstract

Hepatocyte growth factor (HGF) signaling via c-Met is known to promote endothelial cell motility and angiogenesis. We have previously reported that HGF stimulates lamellipodia formation and motility of human lung microvascular endothelial cells (HLMVECs) via PI3K/Akt signal transduction and reactive oxygen species generation. Here, we report a role for HGF-induced intracellular sphingosine-1-phosphate (S1P) generation catalyzed by sphingosine kinase 1 (SphK1), S1P transporter, spinster homolog 2 (Spns2), and S1P receptor, S1P

Indexed as

Cell MovementAnion Transport ProteinsCells, CulturedCortactinEndothelium, VascularHepatocyte Growth FactorHumansLungLysophospholipidsPhosphorylationPhosphotransferases (Alcohol Group Acceptor)Proto-Oncogene Proteins c-metPseudopodiaReceptors, LysosphingolipidSignal TransductionSphingosineAnion Transport ProteinsCortactinCTTN protein, humanHepatocyte Growth FactorHGF protein, humanLysophospholipidsMET protein, humanPhosphotransferases (Alcohol Group Acceptor)Proto-Oncogene Proteins c-metReceptors, LysosphingolipidSphingosinesphingosine 1-phosphateSphingosine KinaseSpns2 protein, humancell signalinghepatocyte growth factor/scatter factor (HGF/SF)lipid signalingsphingosine-1-phosphate (S1P)Sphingosine kinase (SphK)Spns2trans

Identifiers

PMID27864331
PMCPMC5207147
OpenAlexW2554695763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.